Financial Performance - In 2025, the company achieved total operating revenue of 188,405.10 million yuan, a decrease of 10.34% compared to the previous year[2] - The net profit attributable to the parent company was -11,912.41 million yuan, an increase in loss of 84.09% year-on-year[5] - The basic earnings per share decreased to -1.55 yuan, compared to -0.87 yuan in the previous year[2] Assets and Equity - The total assets at the end of the reporting period were 352,969.64 million yuan, an increase of 105.07% from the beginning of the period[3] - The equity attributable to the parent company increased by 185.16% to 278,675.13 million yuan[5] - The significant increase in total assets and equity is attributed to the initial public offering of shares in December 2025, which raised substantial funds[8] Market Strategy - The company plans to enhance market expansion efforts, focusing on new applications in industrial, medical, and automotive sectors[7] - The company will continue to strengthen cooperation with existing RF front-end chip brand customers and accelerate the introduction of a full range of products[7] Inventory and Risks - The company has recognized impairment losses on certain inventories due to structural changes in customer demand and rising material costs[7] - There are no major uncertainties affecting the accuracy of the performance report as of the announcement date[9]

Financial Performance - The total revenue for 2025 reached CNY 148,270.27 million, representing a year-on-year increase of 5.15%[2] - The net profit attributable to the parent company was CNY 26,541.48 million, a decrease of 31.67% compared to the previous year[6] - The net profit excluding non-recurring gains and losses was CNY 25,311.33 million, down 35.11% year-on-year[6] - Operating profit decreased by 33.04% to CNY 28,993.91 million[10] - The basic earnings per share decreased by 32.68% to CNY 1.38[2] Asset and Equity - The company's total assets increased by 11.01% to CNY 388,198.73 million compared to the beginning of the period[7] - The equity attributable to the parent company rose by 15.62% to CNY 278,597.73 million[7] Asset Impairment - The company recognized an asset impairment loss of CNY 8,669.29 million, primarily related to goodwill and fixed assets in the contact lens business[8] Return on Investment - The weighted average return on net assets fell by 7.27 percentage points to 10.05%[2] Cash Flow - Cash flow from operating activities increased by 4.22%, providing support for the company's ongoing development[5]

Financial Performance - The total operating revenue for 2025 was RMB 20.67 million, a significant increase of 5,535.71% compared to RMB 0.3668 million in the previous year[4] - The net profit attributable to the parent company was a loss of RMB 136.69 million, an improvement of RMB 62.81 million compared to a loss of RMB 199.50 million in the previous year[6] - The net profit attributable to the parent company, excluding non-recurring gains and losses, was a loss of RMB 167.37 million, an improvement of RMB 50.14 million compared to a loss of RMB 217.51 million in the previous year[6] - The company’s basic earnings per share for 2025 were -RMB 1.38, compared to -RMB 2.01 in the previous year[4] - The company’s weighted average return on net assets was -12.12%, an improvement from -15.59% in the previous year[4] Assets and Equity - The company’s total assets at the end of the reporting period were RMB 1,314.70 million, a decrease of 3.44% from RMB 1,361.58 million at the beginning of the period[5] - The company’s equity attributable to the parent company decreased by 10.75% to RMB 1,064.12 million from RMB 1,192.25 million[5] Research and Development - The company’s R&D expenses for 2025 were RMB 113.69 million, a decrease of 34.68% from RMB 174.03 million in the previous year[7] Product Development - The first-class new drug, Deutetrabenazine soft capsules (Project No: HC-1119), was approved for sale in May 2025, contributing to the significant increase in revenue[8] Market Strategy - The company is in the early stage of commercializing its drug products, requiring significant investment in market expansion and academic promotion activities[7]

Revenue Performance - Total revenue for 2025 was CNY 133,139.76 million, a decrease of 1.36% compared to the previous year[3] - The company reported a decrease in total revenue due to the impact of the tenth batch of national centralized procurement, but profit growth remained robust[6] Profitability - Net profit attributable to shareholders of the parent company reached CNY 28,324.83 million, an increase of 18.89% year-on-year[3] - Net profit attributable to shareholders of the parent company after deducting non-recurring gains and losses was CNY 20,624.39 million, up 18.01% from the previous year[3] - Basic earnings per share increased to CNY 1.63, reflecting a growth of 19.85%[3] Assets and Equity - Total assets at the end of the reporting period were CNY 379,885.73 million, an increase of 11.73% from the beginning of the period[3] - Shareholders' equity attributable to the parent company was CNY 293,202.71 million, up 8.68% from the beginning of the period[3] Operational Measures - The company implemented measures to optimize revenue structure and enhance cost control, which helped mitigate the impact of the national centralized procurement policy[6] Return on Assets - The weighted average return on net assets increased to 10.09%, up 0.95 percentage points from the previous year[3] Financial Reporting - The financial data presented is preliminary and unaudited, with final figures to be confirmed in the annual report[4]

Financial Performance - Total revenue for 2025 was RMB 453.58 million, a decrease of 16.11% compared to RMB 540.70 million in the previous year[4] - Net profit attributable to shareholders was RMB 73.38 million, down 61.84% from RMB 192.30 million year-on-year[4] - The basic earnings per share decreased to RMB 0.58, a decline of 61.59% from RMB 1.51 in the previous year[4] - The return on equity decreased to 1.41%, down 2.31 percentage points from 3.72% in the previous year[4] - The net profit excluding non-recurring gains and losses was RMB 15.37 million, a decrease of 59.44% from RMB 37.90 million year-on-year[4] Assets and Investments - Total assets at the end of the reporting period were RMB 5,612.12 million, a decrease of 2.72% from RMB 5,769.31 million at the beginning of the period[4] - The company has increased its strategic investment in new technology platforms and is advancing product registration and certification domestically and internationally[6] Market and Operational Challenges - The decline in net profit was primarily due to increased tariffs imposed by the U.S. government, leading to reduced orders in certain markets and increased operating costs[7] - The company is expanding its overseas branch layout, which has resulted in increased sales expenses but is expected to open up space for future growth[6] - The company emphasizes the importance of operational upgrades centered on lean management to enhance efficiency and cost control[6]

Financial Performance - The company achieved total operating revenue of 1,161.14 million yuan, representing a year-on-year growth of 11.89%[3] - The net profit attributable to the parent company was -155.02 million yuan, a reduction in loss of 175.83 million yuan compared to the previous year[5] - The gross profit margin improved by approximately 11 percentage points year-on-year due to cost control and efficiency enhancement measures[6] - The basic earnings per share improved to -1.17 yuan, compared to -2.47 yuan in the previous year[3] - The weighted average return on net assets increased by 6.62 percentage points to -7.62%[3] Business Growth - The company signed new orders worth approximately 1.6 billion yuan, an increase of about 45% year-on-year[7] - The company’s international business revenue increased to approximately 47% of total revenue, reflecting a strategic focus on global expansion[6] Asset Management - Total assets at the end of the reporting period were 2,588.90 million yuan, a decrease of 8.30% from the beginning of the period[4] - The equity attributable to the parent company was 1,947.03 million yuan, down 9.02% from the beginning of the period[4] Market Challenges - The company continues to face pressure on profit margins due to competitive pricing in the market[7]

Financial Performance - In 2025, the company achieved total operating revenue of RMB 1,583,784,788.03, a year-on-year increase of 53.52%[3] - Operating profit for 2025 was RMB 261,205,330.82, reflecting a significant growth of 126.41% compared to the previous year[3] - The net profit attributable to shareholders reached RMB 241,280,791.67, marking an increase of 118.68% year-on-year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was RMB 222,704,423.66, up 140.25% from the previous year[3] - Basic earnings per share for 2025 were RMB 1.74, representing a 117.50% increase compared to the previous year[6] Assets and Equity - Total assets at the end of 2025 amounted to RMB 2,600,844,516.46, a growth of 19.50% from the beginning of the year[5] - Shareholders' equity attributable to the company was RMB 1,976,289,565.74, increasing by 9.52% compared to the start of the year[5] Profitability Indicators - The weighted average return on net assets was 12.78%, up from 6.03% in the previous year, indicating improved profitability[3] Business Drivers - The company attributed its revenue and profit growth to the rapid development of AI computing power and strong demand for high-speed communication connectors and components in servers and data centers[6] Financial Data Disclaimer - The company emphasizes that the financial data is preliminary and subject to final confirmation in the annual report[4]

Financial Performance - The total revenue for the reporting period reached 254.57 million yuan, representing a 95.62% increase compared to the same period last year[3] - The net profit attributable to the parent company was -91.26 million yuan, a reduction in loss of 5.93 million yuan year-on-year[5] - The basic earnings per share for the reporting period was -1.24 yuan, slightly improved from -1.32 yuan in the previous year[3] - The weighted average return on equity was -10.71%, a decrease of 0.63 percentage points compared to the previous year[3] Assets and Equity - The total assets at the end of the reporting period were 932.42 million yuan, a decrease of 3.35% from the beginning of the period[5] - The equity attributable to the parent company decreased by 12.28% to 794.03 million yuan compared to the beginning of the period[5] Strategic Focus - The company focused on four core application areas: BLDC motor drives, industrial and automotive power supplies, new energy and smart grids, and high-reliability power supplies, leading to a steady recovery in revenue[6] - The company increased its R&D investment and talent acquisition to strengthen its technological advantages amid a competitive market environment[6] Impairment and Caution - The company has recognized impairment provisions for assets showing signs of impairment, impacting the financial results[6] - The company emphasizes the importance of cautious investment due to the preliminary nature of the financial data presented[7]

Financial Performance - The company achieved total operating revenue of RMB 2.92 billion, a year-on-year increase of 30.87%[5] - Net profit attributable to shareholders of the parent company reached RMB 1.61 billion, up 50.24% year-on-year[7] - The net profit attributable to shareholders of the parent company, excluding non-recurring gains and losses, was RMB 1.23 billion, reflecting an 85.76% increase year-on-year[7] - The company reported a basic earnings per share of RMB 0.35, representing a 52.17% increase year-on-year[5] - The weighted average return on net assets increased by 1.31 percentage points to 4.01%[5] Assets and Equity - The company's total assets as of December 31, 2025, amounted to RMB 6.22 billion, a growth of 13.95% compared to the beginning of the period[7] - Shareholders' equity attributable to the parent company increased to RMB 4.26 billion, up 8.92% from the beginning of the period[7] Strategic Initiatives - The company completed the acquisition of JAI A/S, enhancing its core competitiveness in the "AI + Vision" industry chain[8] - The company focused on strategic business areas, leading to significant growth in machine vision and related sectors[8] - The company emphasized operational efficiency and cost control, positively impacting net profit growth[8]

证券代码：688696 证券简称：极米科技 公告编号：2026-007 极米科技股份有限公司 2025 年年度业绩快报公告 1 | 加权平均净资产收益率 | 4.87 | 3.89 | 0.98 | | --- | --- | --- | --- | | | 本报告期末 | 本报告期初 | 增减变动幅 度（％） | | 总资产 | 570,065.78 | 531,879.35 | 7.18 | | 归属于母公司的所有者 权益 | 310,295.11 | 294,263.16 | 5.45 | | 股本 | 7,000.00 | 7,000.00 | 0 | | 归属于母公司所有者的 每股净资产（元） | 44.33 | 42.04 | 5.45 | 注：1.本报告期初数同法定披露的上年年末数。 二、经营业绩和财务状况情况说明 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 本公告所载2025年年度主要财务数据为初步核算数据，未经会计师事务所审 计，具体数据以极米科技股份有限公司（以下简称"公司"）2025年年度报告为 ...